INNOVEX INTERNATIONAL INC (INVX)

US4576511079 - Common Stock

14.88  +0.41 (+2.83%)

After market: 14.88 0 (0%)

Fundamental Rating

5

INVX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Energy Equipment & Services industry. No worries on liquidiy or solvency for INVX as it has an excellent financial health rating, but there are worries on the profitability. INVX has a correct valuation and a medium growth rate.



3

1. Profitability

1.1 Basic Checks

INVX had positive earnings in the past year.
INVX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
In multiple years INVX reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 7.98%, INVX is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
INVX has a Return On Equity of 10.00%. This is comparable to the rest of the industry: INVX outperforms 51.72% of its industry peers.
The Return On Invested Capital of INVX (4.92%) is worse than 65.52% of its industry peers.
Industry RankSector Rank
ROA 7.98%
ROE 10%
ROIC 4.92%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

INVX has a Profit Margin of 13.98%. This is amongst the best in the industry. INVX outperforms 84.48% of its industry peers.
The Operating Margin of INVX (9.22%) is comparable to the rest of the industry.
INVX has a Gross Margin of 33.13%. This is in the better half of the industry: INVX outperforms 62.07% of its industry peers.
INVX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.22%
PM (TTM) 13.98%
GM 33.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
The number of shares outstanding for INVX has been increased compared to 1 year ago.
Compared to 5 years ago, INVX has less shares outstanding
INVX has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.20 indicates that INVX is not in any danger for bankruptcy at the moment.
INVX has a better Altman-Z score (4.20) than 89.66% of its industry peers.
The Debt to FCF ratio of INVX is 0.35, which is an excellent value as it means it would take INVX, only 0.35 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of INVX (0.35) is better than 93.10% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that INVX is not too dependend on debt financing.
INVX has a better Debt to Equity ratio (0.01) than 87.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 4.2
ROIC/WACC0.53
WACC9.21%

2.3 Liquidity

A Current Ratio of 3.87 indicates that INVX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.87, INVX belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
A Quick Ratio of 2.17 indicates that INVX has no problem at all paying its short term obligations.
INVX has a Quick ratio of 2.17. This is in the better half of the industry: INVX outperforms 77.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 2.17

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 4773.82% over the past year.
Looking at the last year, INVX shows a very strong growth in Revenue. The Revenue has grown by 63.93%.
The Revenue has been growing slightly by 1.97% on average over the past years.
EPS 1Y (TTM)4773.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1064.94%
Revenue 1Y (TTM)63.93%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%29.49%

3.2 Future

INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 362.49% yearly.
The Revenue is expected to grow by 9.80% on average over the next years. This is quite good.
EPS Next Y24023.08%
EPS Next 2Y838.9%
EPS Next 3Y362.49%
EPS Next 5YN/A
Revenue Next Year51.8%
Revenue Next 2Y11.67%
Revenue Next 3Y9.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.95, the valuation of INVX can be described as very cheap.
96.55% of the companies in the same industry are more expensive than INVX, based on the Price/Earnings ratio.
INVX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
A Price/Forward Earnings ratio of 13.03 indicates a correct valuation of INVX.
60.34% of the companies in the same industry are more expensive than INVX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, INVX is valued a bit cheaper.
Industry RankSector Rank
PE 6.95
Fwd PE 13.03

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, INVX is valued a bit more expensive than 79.31% of the companies in the same industry.
INVX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.67
EV/EBITDA 10.91

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX's earnings are expected to grow with 362.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y838.9%
EPS Next 3Y362.49%

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVEX INTERNATIONAL INC

NYSE:INVX (1/3/2025, 8:04:01 PM)

After market: 14.88 0 (0%)

14.88

+0.41 (+2.83%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner ChangeN/A
Ins Owners1.52%
Ins Owner Change81.93%
Market Cap1.03B
Analysts40
Price Target15.3 (2.82%)
Short Float %N/A
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-110.4%
Min EPS beat(2)-165.36%
Max EPS beat(2)-55.44%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.88%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)10.25%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-34.78%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.95
Fwd PE 13.03
P/S 1.59
P/FCF 15.67
P/OCF 12.37
P/B 1.14
P/tB 1.22
EV/EBITDA 10.91
EPS(TTM)2.14
EY14.38%
EPS(NY)1.14
Fwd EY7.68%
FCF(TTM)0.95
FCFY6.38%
OCF(TTM)1.2
OCFY8.09%
SpS9.35
BVpS13.08
TBVpS12.21
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.98%
ROE 10%
ROCE 6.23%
ROIC 4.92%
ROICexc 5.49%
ROICexgc 5.9%
OM 9.22%
PM (TTM) 13.98%
GM 33.13%
FCFM 10.15%
ROA(3y)-4.28%
ROA(5y)-3.07%
ROE(3y)-4.81%
ROE(5y)-3.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y-1.51%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.14
Cap/Depr 63.47%
Cap/Sales 2.71%
Interest Coverage 250
Cash Conversion 95.34%
Profit Quality 72.65%
Current Ratio 3.87
Quick Ratio 2.17
Altman-Z 4.2
F-Score5
WACC9.21%
ROIC/WACC0.53
Cap/Depr(3y)68.2%
Cap/Depr(5y)55.03%
Cap/Sales(3y)5.33%
Cap/Sales(5y)4.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4773.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1064.94%
EPS Next Y24023.08%
EPS Next 2Y838.9%
EPS Next 3Y362.49%
EPS Next 5YN/A
Revenue 1Y (TTM)63.93%
Revenue growth 3Y5.13%
Revenue growth 5Y1.97%
Sales Q2Q%29.49%
Revenue Next Year51.8%
Revenue Next 2Y11.67%
Revenue Next 3Y9.8%
Revenue Next 5YN/A
EBIT growth 1Y6554.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2314.29%
EBIT Next 3Y135.99%
EBIT Next 5YN/A
FCF growth 1Y317.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.88%
OCF growth 3YN/A
OCF growth 5Y-29.85%